Clinical Trials Directory

Trials / Unknown

UnknownNCT01003522

Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer

Randomised Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer (RESTORE-AIR)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Royal Marsden NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To investigate whether the use of airways stents (metal tubes to open and keep open narrowed airways) together with the standard treatment increases the proportion of patients who can complete a 6min walking distance (6MWD) test at 2 weeks +/- 2days in patients with breathlessness due to lung cancer, when compared to standard treatment alone.

Conditions

Interventions

TypeNameDescription
OTHERArterial puncturePatients will undergo arterial blood gas sampling from the radial artery. This will be done by experienced doctors who are highly skilled in this procedure.
OTHERVenepunctureBlood samples for baseline biochemistry, full blood count, and clotting screen will be taken. In patients additionally providing optional consent blood will be taken for laboratory based basic science research into lung cancer carcinogenesis and pharmacogenetics. Blood will be taken by qualified and experienced nurses, doctors and phlebotomists.
PROCEDUREGeneral anaestheticPatients randomised into the stenting arm will undergo rigid bronchoscopy under general anaesthetic.
PROCEDUREInpatient staysPatients randomised into the stenting arm will be admitted overnight for the procedure
OTHERWalking testAll patients will be asked to complete a 6 minute walking test at baseline and on day 15. Patients randomised into the stent arm (Arm A) will complete a further 6 minute walking test at 24 hours post-stent
OTHERSpirometry & flow volume loop assessmentAll patients will undergo spirometry and flow volume loop assessments at baseline and on day 15.
OTHERBiopsy materialFor patients randomised to stenting and giving additional voluntary consent, 2 pairs of biopsies of tumour tissue, and 1 pair of biopsies of normal airways tissue will be taken for basic scientific research into lung cancer carcinogenesis, and pharmacogenetics.

Timeline

Start date
2008-09-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2009-10-28
Last updated
2009-10-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01003522. Inclusion in this directory is not an endorsement.